Clinical Trial: Retrospective Study on Predicting Benign or Malignant Breast Nodules Based on Serum Antibody Protein Targets (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective Study on Predicting Benign or Malignant Breast Nodules Based on Serum Antibody Protein Targets'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131766

Registration Time: 2026/09/06

Type: Observational study

Primary Sponsor: Sun Yat-sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=309545

Published by HT Digital Content Services with permission from Health Daily Digest....